unknown
Stage
3
Investors
About
Cosyne builds a hypothesis-free drug discovery platform for oncology that applies genetic computational systems analysis and polymathic AI to identify therapeutic targets and candidates for deadly cancers.
Explore Cosyne's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.